Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax COVID-19 shot have slumped.

The first vaccines are due to be produced at the new facility in 2025. It also said the alliance will see Moderna invest in R&D in the UK over the next 10 years, including running a number of ...

No other vaccines are given at such a high frequency, but experts say there’s no reason to believe that the vaccines — and in particular, the mRNA vaccines from Pfizer and Moderna — aren’t ...

Moderna is trying to find a path to profitability in the wake of disappointing vaccine sales. In September, the company said it aims to reduce its research and development budget by about 20 ...

Benn et al, LETHAL TOXIN NEUTRALIZING ANTIBODY RESPONSE INDUCED FOLLOWING ORAL VACCINATION WITH A MICROENCAPSULATED BACILLUS ...

Its logo features obvious black and white-themed branding, which should perhaps not be a surprise considering Pokémon Black and White region Unova is next on the docket to be featured in the game ...

Anyone who doubts that a second Trump term would take vaccine skepticism into the mainstream of American government and life should watch Kaitlan Collins’ interview on CNN Wednesday with the co ...

Pfizer stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Raccoon dogs may carry and transmit COVID-19–causing SARS-CoV-2 to humans, although critical differences in the enzyme that facilitates viral entry into the cell may make the jump unlikely, a study in ...

From birth to death, Black people face systemic disadvantages in American life more than 150 years after slavery was abolished. Inequality between white and Black Americans persists in almost ...

said the Drug Control Authority (DCA) agreed to give conditional approval to Spikevax, or what is commonly known as the Moderna Covid-19 vaccine.